Heidelberg Engineering Joins CCOI as Part of EssilorLuxottica’s Vision Architect Membership

Heidelberg Engineering announced that it has joined the Collaborative Community on Ophthalmic Innovation (CCOI), entering through EssilorLuxottica’s Vision Architect membership tier. 

CCOI, a public–private forum, brings together patients, clinicians, researchers, regulators, industry, and payors to accelerate the development, assessment, and adoption of ophthalmic medical products. As part of its involvement, Heidelberg Engineering will contribute to the community’s age-related macular degeneration (AMD) and glaucoma workstreams. The company said it will collaborate with partners to harmonize clinically meaningful endpoints, establish interoperable data standards, and shape pathways that help promising technologies reach patients more efficiently—while maintaining the highest standards of quality and safety.

“Heidelberg Engineering has built its reputation on high-quality, multimodal ophthalmic imaging that is trusted across routine care, clinical studies, and vision-science research,” said Kfir Azoulay, Managing Director of Heidelberg Engineering, who will serve as the company’s representative within the CCOI working groups. “By engaging in CCOI’s workstreams in general, and AMD and glaucoma in particular, we aim to contribute our imaging and data expertise to consensus efforts on endpoints, validation frameworks, and real-world deployment so that innovative diagnostics and therapies can be responsibly integrated into care.”

“CCOI connects every stakeholder in the innovation ecosystem so that evidence, not geography or silos, defines the path to patient access. We welcome Heidelberg Engineering’s participation via EssilorLuxottica’s Vision Architect membership, reflecting a strong dedication to advancing the science, standards, and trust that drive responsible innovation in eye care," said CCOI’s Chief Executive Officer, Malvina Eydelman, MD, welcomed the announcement, noting the value of broad, cross-sector collaboration:

Heidelberg Engineering will support CCOI initiatives aimed at defining and validating patient-centered, clinically meaningful measures—particularly those using structural and functional imaging. These efforts are intended to reduce uncertainty in clinical development across multiple ocular diseases. Heidelberg will participate in CCOI discussions on AI evaluation, reference standards, and implementation science, helping ensure that AI-enabled workflows support access, equity, and improved clinical outcomes.